These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 29251384

  • 1. Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B.
    Wu X, Cai B, Su Z, Li Y, Xu J, Deng R, Wang L.
    J Clin Lab Anal; 2018 May; 32(4):e22341. PubMed ID: 29251384
    [Abstract] [Full Text] [Related]

  • 2. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
    Li Q, Song J, Huang Y, Li X, Zhuo Q, Li W, Chen C, Lu C, Qi X, Chen L.
    Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels.
    Wang L, Li J, Yang K, Zhang H, Wang Q, Lv X, Guan S.
    Medicine (Baltimore); 2020 Jun 05; 99(23):e20548. PubMed ID: 32502018
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
    Li Q, Lu C, Li W, Huang Y, Chen L.
    Oncotarget; 2017 Apr 25; 8(17):28641-28649. PubMed ID: 28415736
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC, Liu H, Liu XY, Ma LN, Guan YH, Luo X, Ding XC.
    World J Gastroenterol; 2017 Nov 07; 23(41):7425-7432. PubMed ID: 29151696
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR), red cell distribution width (RDW), aspartate aminotransferase-to-platelet ratio index (APRI), and the fibrosis-4 index (FIB4) compared with liver biopsy in patients with drug-induced liver injury (DILI).
    Wan M, Xu H, Li D, Wang L, Li X.
    Medicine (Baltimore); 2021 Feb 12; 100(6):e24723. PubMed ID: 33578617
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Noninvasive models for the prediction of liver fibrosis in patients with chronic hepatitis B.
    Wang J, Sun X, Wei S, Chen X, Zhu H, Liantang Y, Bao R, Du Y.
    BMC Gastroenterol; 2024 May 24; 24(1):183. PubMed ID: 38783185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.